Clinical Trial Update: Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating penpulimab with the GP chemotherapy regimen, with or without anlotinib, as neoadjuvant therapy for locoregionally advanced nasopha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Anlotinib (anlotinib)
• Gemcitabine + Cisplatin (GP regimen) (gemcitabine and cisplatin)
• Penpulimab

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING